Order and treatment record
Bring or send the signed order, diagnosis, intended dose, last injection or oral dose, next due date, initiation history, and prescriber contact details.
Invega Hafyera injection care in NYC
Invega Hafyera is a six-month paliperidone palmitate injection for schizophrenia in adults. It follows adequate treatment with a monthly paliperidone injection for at least four months or a three-month injection for at least one cycle.
Two ways to coordinate care: If an outside psychiatrist prescribes and manages the treatment, Nao can review an accepted order and records for in-clinic administration. If the patient needs Nao to manage treatment, Nao psychiatry can evaluate, prescribe when appropriate, and provide follow-up. Invega Hafyera is a six-month paliperidone palmitate injection for adults with schizophrenia who are already adequately treated with a monthly or three-month paliperidone injection. Nao Medical can coordinate an accepted outside order, patient-specific delivery, administration, visit monitoring, and ongoing psychiatry. Stabilization records, renal review, coverage, medication arrival, and the eligible clinic must be confirmed first.
Records first, appointment second
A complete handoff helps prevent an incorrect dose, an avoidable delay, or a visit at the wrong clinic.
Six-month Invega Hafyera
Hafyera is a six-month, buttock-muscle paliperidone injection for adults with schizophrenia after specified shorter-interval treatment. The label requires adequate monthly paliperidone for at least four months or at least one three-month cycle, using eligible prior strengths. The prescriber checks response, tolerability and kidney function before selecting it. It is not a direct first-step injection. Six-month medicine administration does not mean that symptom reviews, physical-health checks or psychosocial care should wait six months.
Invega Hafyera
Invega Hafyera is a six-month paliperidone palmitate injection for schizophrenia in adults. It follows adequate treatment with a monthly paliperidone injection for at least four months or a three-month injection for at least one cycle. It is not a first treatment for newly diagnosed schizophrenia. A healthcare professional gives Hafyera into the buttock muscle only.
How Invega Hafyera works
The formulation releases paliperidone over a much longer period. Paliperidone is thought to act by blocking dopamine and serotonin receptors. Six-month dosing describes administration frequency, not how quickly an unwanted effect will resolve. Treatment goals and symptoms still need review during the interval.
Eligibility: Invega Hafyera
Only specified monthly or three-month strengths have labelled Hafyera conversions. Before switching from monthly treatment, the label recommends the last two monthly doses be the same strength. The prescriber checks response, tolerability, kidney function and whether the longer period fits your preferences and care arrangements. Moderate or severe renal impairment is a restriction across these long-acting paliperidone products.
What to expect: Invega Hafyera
Review the shorter-interval treatment history
Bring the exact product names, doses and dates. Talk about symptoms, side effects and the reason for considering six-month dosing. Do not infer eligibility from the number of injections alone.
Confirm the transition and administration
The clinician chooses the corresponding labelled strength and scheduled transition date. Hafyera uses a gluteal injection and has its own preparation instructions. It cannot be substituted vial-for-vial with Sustenna or Trinza.
Set follow-up beyond the injection date
Arrange the next injection plus interim psychiatric and health monitoring. Ask who will manage new symptoms, adverse effects or a move to another city during the six-month interval. Long intervals make a reliable record especially useful.
Preparing for your appointment
Bring the exact product name, prescribed strength, last injection date, oral medicine list and the responsible prescriber’s contact information. Include discharge notes, recent blood tests and any written start or restart plan. Tell the team about pregnancy, breastfeeding, allergies, seizures, fainting, substance use and new medicines or supplements. If a dose is delayed or records are unclear, contact the prescriber before travelling to an administration visit.
Risks and when to seek help
The boxed warning states that antipsychotics increase the risk of death in older adults with dementia-related psychosis. This medicine is not approved for that use. Paliperidone can cause drowsiness, dizziness, movement symptoms, weight gain and changes in blood sugar or cholesterol. It can also raise prolactin, which may affect periods, breast symptoms or sexual function. Report these changes rather than stopping treatment yourself. Heart rhythm risk and blood pressure need review. Avoid driving or hazardous work until you know how treatment affects you. Seek emergency care for severe trouble breathing, throat or tongue swelling, loss of consciousness, or high fever with severe muscle stiffness and confusion. Contact the treating team promptly for new involuntary movements, severe restlessness, worsening psychosis, marked dizziness or troublesome injection-site symptoms. Do not wait for the next routine injection to report a serious concern.
Follow-up and treatment review
The label permits a limited window up to two weeks before or three weeks after the scheduled six-month dose. Beyond six months and three weeks, it requires a specific monthly paliperidone re-initiation plan. Longer gaps change that plan, and more than eleven months generally requires re-establishing monthly treatment before resuming Hafyera. Do not book a routine Hafyera injection without reviewing the gap.
Appointments, costs and coverage
Before an injection appointment, ask which clinic can accept the prescription, how the medicine will be obtained, and which costs belong to the medicine, administration and psychiatry follow-up. A benefits check, prior authorization and medicine delivery are different steps. Ask for the proposed cost before each step. Manufacturer assistance has its own eligibility rules. Office-visit coverage does not establish medication coverage, and a listed clinic does not establish that the product is stocked or can be given there today.
Questions about your care
Can Nao Medical give Invega Hafyera ordered by an outside psychiatrist?
Nao Medical can coordinate psychiatric injection care with your prescribing psychiatrist. Share the current order, exact medicine, last dose date and treatment history through the confirmed clinical intake process. The clinicians review product-specific initiation or restart requirements and arrange medication delivery, administration and follow-up. Keep your existing treatment plan until the next appointment is agreed.
What is the approved use of Invega Hafyera? How often is Invega Hafyera given, and where is it injected?
Invega Hafyera is a six-month paliperidone palmitate injection for schizophrenia in adults. It follows adequate treatment with a monthly paliperidone injection for at least four months or a three-month injection for at least one cycle. It is not a first treatment for newly diagnosed schizophrenia. A healthcare professional gives Hafyera into the buttock muscle only.
Is oral medication or a loading regimen needed when starting Invega Hafyera?
Only specified monthly or three-month strengths have labelled Hafyera conversions. Before switching from monthly treatment, the label recommends the last two monthly doses be the same strength. The prescriber checks response, tolerability, kidney function and whether the longer period fits your preferences and care arrangements. Moderate or severe renal impairment is a restriction across these long-acting paliperidone products.
Bring the exact product names, doses and dates. Talk about symptoms, side effects and the reason for considering six-month dosing. Do not infer eligibility from the number of injections alone.
The clinician chooses the corresponding labelled strength and scheduled transition date. Hafyera uses a gluteal injection and has its own preparation instructions. It cannot be substituted vial-for-vial with Sustenna or Trinza.
Arrange the next injection plus interim psychiatric and health monitoring. Ask who will manage new symptoms, adverse effects or a move to another city during the six-month interval. Long intervals make a reliable record especially useful.
What happens if a Invega Hafyera dose is late?
The label permits a limited window up to two weeks before or three weeks after the scheduled six-month dose. Beyond six months and three weeks, it requires a specific monthly paliperidone re-initiation plan. Longer gaps change that plan, and more than eleven months generally requires re-establishing monthly treatment before resuming Hafyera. Do not book a routine Hafyera injection without reviewing the gap.
Only specified monthly or three-month strengths have labelled Hafyera conversions. Before switching from monthly treatment, the label recommends the last two monthly doses be the same strength. The prescriber checks response, tolerability, kidney function and whether the longer period fits your preferences and care arrangements. Moderate or severe renal impairment is a restriction across these long-acting paliperidone products.
Can Nao switch me to Invega Hafyera from another medication?
A switch needs the responsible psychiatrist's documented plan, not just an administration appointment. Review the exact current product, strength, last dose, response and tolerability. The new injection has its own indication, prior-treatment, loading or oral-coverage rules. Ask whether Nao provides the prescribing evaluation or accepts an outside order, and confirm delivery, the administering site and follow-up before changing treatment. Do not stop or convert medicines yourself.
What monitoring is important with Invega Hafyera?
Continuing antipsychotic care reviews symptoms, daily function, injection dates, movement symptoms, sedation, falls, weight, blood pressure and medicine-specific blood tests. Blood sugar/lipids, prolactin or heart-rhythm assessment may be relevant depending on the product and history. Ask the psychiatrist which tests are due and who reviews them. An administration-only visit does not replace that care. Report new involuntary movements, marked restlessness, fainting or troublesome injection-site changes promptly.
Does Invega Hafyera have an active FDA REMS?
The reviewed current US prescribing information for Invega Hafyera does not specify a restricted REMS administration/distribution program. That does not remove the medicine’s prescribing, administration, initiation or monitoring requirements. Confirm the exact product and current FDA status with the treating clinician and dispensing service; a manufacturer access program is not itself an FDA REMS.
Will insurance cover Invega Hafyera?
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
Can any Sustenna or Trinza dose be converted to Hafyera?
No. The label identifies eligible prior strengths and treatment requirements. The prescriber must check the exact product and strength.
Medical sources
What to prepare before scheduling
Medication and safety record
Include current medicines, allergies, prior adverse effects, pregnancy or breastfeeding considerations, recent hospitalization records, and relevant laboratory or monitoring results.
Coverage and delivery details
Share insurance cards, the specialty pharmacy or distributor if known, prior authorization status, and the intended patient-specific delivery destination.
Timing confirmation
Wait for the care team to confirm order acceptance, medication arrival, the eligible clinic, trained staff, and appointment time before traveling.
Evaluation and coordination locations across New York
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods. The administration clinic will be confirmed separately by the care team.
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods. The administration clinic will be confirmed separately by the care team.
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods. The administration clinic will be confirmed separately by the care team.
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods. The administration clinic will be confirmed separately by the care team.
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities. The administration clinic will be confirmed separately by the care team.
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods. The administration clinic will be confirmed separately by the care team.
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods. The administration clinic will be confirmed separately by the care team.
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods. The administration clinic will be confirmed separately by the care team.
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities. The administration clinic will be confirmed separately by the care team.
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods. The administration clinic will be confirmed separately by the care team.
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
A nearby Nao Medical access point for evaluation, records coordination, and follow-up planning for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods. The administration clinic will be confirmed separately by the care team.
- DailyMed: current Invega Hafyera prescribing information
- FDA: current active REMS database
- J&J withMe savings and support
- FDA MedWatch: report a suspected medication problem
Official sources checked August 1, 2026. The DailyMed label shown above has an effective date of 2025-02-18 and identifies prescribing-information revision 01/2025. Questions or corrections about this medical information can be sent to service@naomedical.com.
Content was updated August 4, 2026 using the sources cited above. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.